Skip to main content

Table 3 Short term (in-hospital or 30-days) outcomes of TTVI devices

From: Advances in transcatheter mitral and tricuspid therapies

 

Trial/study

Technical successa

Mortality

TR volume reduction (mL)

TriAlign

SCOUT I [67] NCT02574650 SCOUT II is enrolling

12/15

0

−2.7 ± 39.5

TriCinch

Giannini and Colombo [66] PREVENT ongoing NCT03632967

20/24

Cardioband

TRI-REPAIR [68] TriBAND ongoing NCT03779490

28/30

2/30

−35.6 ± 35.3

MitraClip and TriClip

Nickenig et al. [69] TRILUMINATE NCT03227757 [70]

6/64

10/85

3/64

0

−26.4 ± 7.8

− 18.6 ± 21.2

FORMA

Perlman and Dvir [71,72,73] SPACER enrolling NCT02787408

2/47

  1. a no standardized definition for “technical success” for TTVI